Literature DB >> 14563161

Anti-angiogenesis effects of borrelidin are mediated through distinct pathways: threonyl-tRNA synthetase and caspases are independently involved in suppression of proliferation and induction of apoptosis in endothelial cells.

Takanori Kawamura1, Diana Liu, Murray J Towle, Rena Kageyama, Naoko Tsukahara, Toshiaki Wakabayashi, Bruce A Littlefield.   

Abstract

Borrelidin, an antibiotic with anti-angiogenic activity, not only suppresses new capillary tube formation, but also collapses formed capillary tubes in a rat aorta culture model. Since it selectively inhibits threonyl-tRNA synthetase, we examined the effect of threonine on its anti-angiogenic activity. We found that a high concentration of threonine (1 mM) attenuated the ability of borrelidin to inhibit both capillary tube formation in the rat aorta culture model and human umbilical vein endothelial cells (HUVEC) proliferation, yet did not affect the ability of borrelidin to collapse formed capillary tubes or to induce apoptosis in HUVEC. Borrelidin activated caspase-3 and -8, and inhibitors of both caspase-3 and -8 suppressed borrelidin-induced apoptosis in HUVEC. Taken together, these data suggest that the anti-angiogenic effects of borrelidin are mediated through at least two mechanisms, i.e. one threonine-dependent and the other threonine-independent, and borrelidin induces apoptosis in endothelial cells via the caspase-8/-3 pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563161     DOI: 10.7164/antibiotics.56.709

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  15 in total

Review 1.  Prospects for aminoacyl-tRNA synthetase inhibitors as new antimicrobial agents.

Authors:  Julian Gregston Hurdle; Alexander John O'Neill; Ian Chopra
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 2.  Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.

Authors:  Christopher S Francklyn; Patrick Mullen
Journal:  J Biol Chem       Date:  2019-01-22       Impact factor: 5.157

3.  Borrelidin, a small molecule nitrile-containing macrolide inhibitor of threonyl-tRNA synthetase, is a potent inducer of apoptosis in acute lymphoblastic leukemia.

Authors:  Darya Habibi; Nadya Ogloff; Reza B Jalili; Arla Yost; Andrew P Weng; Aziz Ghahary; Christopher J Ong
Journal:  Invest New Drugs       Date:  2011-06-17       Impact factor: 3.850

4.  Liposomal borrelidin for treatment of metastatic breast cancer.

Authors:  Moonkyoung Jeong; Heegon Kim; Sunghoon Kim; Ji-Ho Park
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

5.  Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo.

Authors:  Eva Maria Novoa; Noelia Camacho; Anna Tor; Barrie Wilkinson; Steven Moss; Patricia Marín-García; Isabel G Azcárate; José M Bautista; Adam C Mirando; Christopher S Francklyn; Sònia Varon; Miriam Royo; Alfred Cortés; Lluís Ribas de Pouplana
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-08       Impact factor: 11.205

6.  Borrelidin Induces the Unfolded Protein Response in Oral Cancer Cells and Chop-Dependent Apoptosis.

Authors:  Alpa Sidhu; Justin R Miller; Ashootosh Tripathi; Danielle M Garshott; Amy L Brownell; Daniel J Chiego; Carl Arevang; Qinghua Zeng; Leah C Jackson; Shelby A Bechler; Michael U Callaghan; George H Yoo; Seema Sethi; Ho-Sheng Lin; Joseph H Callaghan; Giselle Tamayo-Castillo; David H Sherman; Randal J Kaufman; Andrew M Fribley
Journal:  ACS Med Chem Lett       Date:  2015-09-08       Impact factor: 4.345

7.  Insights into the preclinical treatment of blood-stage malaria by the antibiotic borrelidin.

Authors:  I G Azcárate; P Marín-García; N Camacho; S Pérez-Benavente; A Puyet; A Diez; L Ribas de Pouplana; J M Bautista
Journal:  Br J Pharmacol       Date:  2013-06       Impact factor: 8.739

8.  Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms.

Authors:  Jeanette Woolard; William Vousden; Steven J Moss; Arjun Krishnakumar; Melissa Vr Gammons; David G Nowak; Neil Dixon; Jason Micklefield; Astrid Spannhoff; Mark T Bedford; Matthew A Gregory; Christine J Martin; Peter F Leadlay; Ming Q Zhang; Steven J Harper; David O Bates; Barrie Wilkinson
Journal:  Chem Sci       Date:  2011-02-01       Impact factor: 9.825

9.  Aminoacyl-tRNA synthetase dependent angiogenesis revealed by a bioengineered macrolide inhibitor.

Authors:  Adam C Mirando; Pengfei Fang; Tamara F Williams; Linda C Baldor; Alan K Howe; Alicia M Ebert; Barrie Wilkinson; Karen M Lounsbury; Min Guo; Christopher S Francklyn
Journal:  Sci Rep       Date:  2015-08-14       Impact factor: 4.379

10.  Secreted Threonyl-tRNA synthetase stimulates endothelial cell migration and angiogenesis.

Authors:  Tamara F Williams; Adam C Mirando; Barrie Wilkinson; Christopher S Francklyn; Karen M Lounsbury
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.